In a surprise move, Health Commissioner Oliver Várhelyi announced at the Medicines for Europe Annual Conference that the EU Biotech Act will go ahead this year, reversing its provious delay from Q3 2025 to Q3 2026. The legislation has now been fast-tracked because the Commission recognised biotechnology’s rising geostrategic weight.
Laverock Therapeutics bags additional £6.5m seed money
Latest NewsBritish targeted gene silencing specialist Laverock Therapeutics Ltd has expanded its seed funding to £20m by a new financing round led by xx and xx. The company said it will use the funds to…l
Unlocking the Future of Precision Biology with Spatial Cell Sorting
slider, Sponsored PublicationsSpatial precision in cell analysis is revolutionizing biomedical research. SLACS (Spatially-resolved Laser Activated Cell Sorting) uniquely isolates live microniches within tissues, preserving spatial context and enabling deep biological insights.
EU Commissioner Várhelyi revives Biotech Act for 2025
Latest NewsIn a surprise move, Health Commissioner Oliver Várhelyi announced at the Medicines for Europe Annual Conference that the EU Biotech Act will go ahead this year, reversing its provious delay from Q3 2025 to Q3 2026. The legislation has now been fast-tracked because the Commission recognised biotechnology’s rising geostrategic weight.
UK to invest £380m in Engineering Biology
Latest NewsThe UK government has unveiled a new industrial strategy that includes a commitment to invest £380m in engineering biology. The package comprises an initial £196m for research and development, and a further £184m for the expansion and modernisation of pilot and scale-up infrastructure.
The Bridge to your success
slider, Sponsored PublicationsCustomized Enzymes and Reagents from New England Biolabs. Creating the right partnership is essential when pioneering a new life science product.
New CEO – new chapter
AppointmentsMC2 Therapeutics A/S, a Hørsholm-based pharmaceutical company focused on topical therapies in inflammatory skin conditions, announced the appointment of Trine Ahlgreen as Chief Executive Officer at the end of May.
Sonrai and Plectonic Biotech partner to advance cancer immunotherapies
Latest NewsUnder a new partnership, Plectonic Biotech will use Sonrai’s AI-powered multi-omics platform to speed up development of its Logybody cancer treatment technology. The approach aims to cut side effects and improve precision.
Italy and Germany block central green deal legislation
Latest NewsThe European Commission has scraped a key piece of Green Deal legislation following political shifts within the European Parliament. The move came after Italy, governed by a far-right administration of Georgia Meloni, aligned itself with the European People’s Party (EPP) on the matter.
Cellular Origines partners with Johnson & Johnson
Associations, Latest NewsBritish gene and cell therapy manufacturing specialist Cellular Origins Ltd has entered into a collaboration with Johnson & Johnson to develop a scalable, end-to-end automated platform for autologous CAR-T cell manufacturing.
Industry veteran appointed
AppointmentsItalian Sibylla Biotech has appointed a new Chairman of the Board of Directors: Dieter Weinand, former President, CEO and Chairman of the Board of Bayer Pharmaceuticals AG.